Editas Medicine Inc.
EDIT | NASDAQ
$2.85
+$0.02 (+0.71%)
Sep 22, 2026, 10:47 AM ET · Market open
Fiscal Year Period Ending | FY 2025 Dec 30, 2025 | FY 2024 Dec 30, 2024 | FY 2023 Dec 30, 2023 | FY 2022 Dec 30, 2022 | FY 2021 Dec 30, 2021 | FY 2020 Dec 30, 2020 |
|---|---|---|---|---|---|---|
Revenue | 40.52M | 32.31M | 78.12M | 19.71M | 25.54M | 90.73M |
Cost of Revenue | n/a | 199.25M | 6.06M | 6.34M | 5.05M | 158M |
Gross Profit | 40.52M | -166.93M | 72.06M | 13.38M | 20.49M | -67.26M |
Operating Income | -99.34M | -251.15M | -169.18M | -225.95M | -193.15M | -134.84M |
Interest Income | 8.31M | 14.06M | 17.57M | 5.52M | 607K | 2.61M |
Pretax Income | -160.06M | -237.09M | -153.22M | -220.43M | -192.5M | -115.98M |
Net Income | -160.06M | -237.09M | -153.22M | -220.43M | -192.5M | -115.98M |
Selling & General & Admin | 49.9M | 71.99M | 69.65M | 70.7M | 76.18M | 67.58M |
Research & Development | 89.95M | 199.25M | 177.65M | 174.96M | 142.51M | 158M |
Other Expenses | n/a | -187.02M | -6.06M | -6.34M | -5.05M | -158M |
Operating Expenses | 139.86M | 84.22M | 241.24M | 239.33M | 213.64M | 67.58M |
Interest Expense | 6.17M | n/a | n/a | n/a | n/a | n/a |
Selling & Marketing Expenses | n/a | n/a | n/a | n/a | n/a | n/a |
Cost & Expenses | 139.86M | 283.47M | 247.3M | 245.66M | 218.69M | 225.57M |
Income Tax Expense | n/a | n/a | n/a | n/a | n/a | n/a |
Shares Outstanding (Basic) | 88.75M | 82.34M | 75.97M | 68.66M | 67.62M | 58.61M |
Shares Outstanding (Diluted) | 88.75M | 82.34M | 75.97M | 68.66M | 67.62M | 58.61M |
EPS (Basic) | -1.80 | -2.88 | -2.02 | -3.21 | -2.85 | -1.98 |
EPS (Diluted) | -1.80 | -2.88 | -2.02 | -3.21 | -2.85 | -1.98 |
EBITDA | -148.61M | -233.11M | -147.16M | -214.1M | -187.45M | -130.88M |
EBIT | -153.89M | -238.92M | -153.22M | -220.43M | -192.5M | -134.84M |
Depreciation & Amortization | 5.28M | 5.81M | 6.06M | 6.34M | 5.05M | 3.96M |
Add to Watchlist
Select watchlists to add or remove EDIT